USFDA completes inspection at Divi’s Laboratories’ Unit-II facility in Andhra Pradesh

01 Feb 2020 Evaluate

US Food and Drug Administration (USFDA) has completed inspection at Divi’s Laboratories’ Unit-II, Village Chippada, Bheemunipatnam District in the state of Andhra Pradesh. The inspection was conducted from January 27 to 31, 2020. The inspection has been concluded with no ‘483’ observations.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

Divis Lab Share Price

3755.15 39.60 (1.07%)
16-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1536.95
Dr. Reddys Lab 6038.00
Cipla 1384.30
Zydus Lifesciences 937.80
Lupin 1613.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.